Heart Failure Reviews

Papers
(The TQCC of Heart Failure Reviews is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome198
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis125
The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy—a meta analysis59
Deciphering hypertrophic cardiomyopathy with electrocardiography51
How to deal with low-flow low-gradient aortic stenosis and reduced left ventricle ejection fraction: from literature review to tips for clinical practice40
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?36
Prognostic value of left ventricular global longitudinal strain in mitral regurgitation: a systematic review34
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris34
An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turning32
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program32
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction31
Social and environmental risks as contributors to the clinical course of heart failure30
Meta-analysis addressing the impact of cardiovascular-acting medication on peak oxygen uptake of patients with HFpEF29
Can mechanical circulatory support be an effective treatment for HFpEF patients?27
Cardiovascular disease associated with methamphetamine use: a review25
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement24
Ambulatory factors influencing pulmonary artery pressure waveforms and implications for clinical practice24
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment23
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism23
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis23
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications22
The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis22
Etiology and pathophysiology of heart failure in people with HIV21
The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases21
COVID-19 and myocarditis: a systematic review and overview of current challenges20
Trends and complications associated with acute new-onset heart failure: a National Readmissions Database–based cohort study20
The genetics of cardiac amyloidosis19
Left ventricular hypertrophy and sudden cardiac death19
Subclinical cardiac damage in cancer patients before chemotherapy19
Creatine deficiency and heart failure19
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy19
The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literature18
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition18
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
The role of TAVR in patients with heart failure: do we have the responses to all questions?17
Biomarkers for the diagnosis and management of heart failure17
Reply to the letter to the editor16
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions16
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction16
Diagnosis of cardiac sarcoidosis: a primer for non-imagers16
Letter to the Editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis”15
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction14
Large animal models of heart failure with preserved ejection fraction13
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?13
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid13
0.049461126327515